Global Animal Parasiticides Market

MARKET SCOPE:

The global animal parasiticides market is projected to grow significantly, registering a CAGR of 5.2% during the forecast period (2026 – 2034).

The growth of the global animal parasiticides market is thriving a new direction, influenced by influential factors. The onward trend in infestations of parasites in both companion animals as well as livestock greatly outweighs, as these infestations may lead to serious health concerns as well as economic losses in the agriculture sector. The emergence of climate change and the movement of animals across borders has subsequently contributed to a rise of parasites, therefore, creating more public and veterinarian demand for products to control the infestation. Furthermore, the increase in awareness of zoonotic diseases (animal to human) is driving demand of these types of products, because controlling these types of infections can affect public health.

Additional growth factors include improvements made in veterinary medicine and new product formulations. Options like biologics, long-acting treatments and targeted delivery systems have improved parasite effectiveness and safety that most veterinarians and pet owners will use. The expansion of the livestock industry in developing economies, the number of new pet owners globally and some governments supporting food safety and controlling the parasites with mandatory standards in livestock and pet animals is also fuelling demand and utilization of parasiticides. Ultimately, animal health management practices with appropriation of veterinary and parasiticides products, used as demand will be regulated to all animals as part of a health management approach.

MARKET OVERVIEW:

Driver: Rising Prevalence of Parasitic Infections Driving Animal Parasiticides Demand

The rising prevalence of parasitic infections in livestock as well as companion animals is a primary driver of the global market for animal parasiticides. Parasites in domestic animals include ticks, fleas, lice, mites and worms. Heavy infestations can have debilitating health consequences including anemia, reduced weight gain and loss of reproduction, even death. Livestock invested with parasites suffer reductions in productivity with a corresponding loss in income. In companion animals, burdened animals incur higher veterinary costs and deteriorate in health.

An additional factor affecting the market is heightened awareness regarding zoonotic parasites, those that can infect people from animals. Pet owners and farmers are increasingly being more responsible for investing in parasite prevention education and products such as oral medications, topical spot-on medications and long-acting collars, that help reduce the risks of parasites and zoonotic disease effects to both human and animal health. These factors combined with the need to reduce impacts on livestock production from parasites keep solidifying the adoption of animal parasiticides globally.

Restraint: Stringent Regulatory Frameworks Limiting Market Expansion

The strict regulations for veterinary medicines impose a significant limitation on the animal parasiticides market. Regulators require many tests and safety data before permitting any parasiticides to be commercially used. Moreover, there are restrictions on the site of application for certain parasiticides based on chemical residues in meat, milk, and eggs of food producing animals.

As well, compliance with the regulations often comes at a high cost, and not complying with them could lead to product recalls and/or legal sanctions. All of these concerns pose several challenges for manufacturers, and slow down the launch of new formulations and hinder overall growth.

Opportunity: Growth in Pet Ownership and Companion Animal Care

The animal parasiticides industry is set to experience significant growth as both the number of pets globally and the emphasis on the health and well-being of companion animals increases. The urbanization of cities, increased disposable incomes, and changes to lifestyles have led to more pet owners wanting to provide preventive care and management of parasites.

Overall demand for easy-to-administer and novel parasiticides is growing, including oral (tablet) products, spot-on products, and long-acting collars for parasites (fleas, ticks, and worms). This forms a great opportunity for companies to introduce new, innovative, convenient, and safe parasiticides for cows; each of which would be considered a unique product for the significant and growing companion animal segment.

SEGMENTATION ANALYSIS:

The Companion Animal Segment is anticipated to grow significantly during the forecast period

The companion animals segment of the animal parasiticides market is expected to grow significantly during the forecast period, primarily due to an increase in pet owners and a greater emphasis on preventive pet healthcare. Since dogs and cats are prone to parasites like fleas, ticks, and intestinal worms, people are demanding parasite prevention specifically. The growing trend of preventive offerings, and higher consumer spending on veterinary services is driving companion animal parasite medicine growth. Other companion animals affect the companion animal parasiticides market, but to a lesser extent than dogs and cats.

REGIONAL ANALYSIS:

The North America region is set to witness significant growth during the forecast period

The North America animal parasiticides market is expected to see steady growth during the forecast period due to advances in veterinary diagnostic laboratories and a vigorous awareness of parasitic infections and the mechanisms of prevention. The United States and Canada account for a large share of the total market share due the substantial amount of companion animal (dogs and cats) populations and consumer discretionary spending towards animal health. The maturation and availability of product formulations (long-acting, and biologics, etc.) has improved the disease prevention position of parasiticides in the North American region.

Moreover, labor patterns related pandemic, where citizens are confined indoors are now requiring awareness of zoonotic diseases and the emphasis of livestock health as well. The capital investment in legislative regulations concerning animal health and the accessibility of veterinary services in certain regions have also acted to heighten the perceived need of inhibit parasiticides application to avoid infections in farm animals and companion animals consumers are likely to adopt. Firms are also providing products which are being targeted and with safer product formulations. This is likely to grow even more wildlife will be part of the experience.

The Asia Pacific animal parasiticides market is expected to grow at the swiftest pace over the rest of the forecast period. Being primed for growth due to urbanization, rising disposable incomes, and a growing number of ownership of pets, and the rapid expansion of the livestock industry in countries such as China, India, and Southeast Asian countries. Awareness about the prevention of parasite infestations, as veterinary services continue to improve will also contribute to market growth. Overall, Asia Pacific will provide exceptional opportunities for firms seeking to expand their presence in emerging markets.

COMPETITIVE ANALYSIS:

The global animal parasiticides market is reasonably competitive with mergers, acquisitions, and Product launches. See some of the major key players in the market.

• Norbrook Laboratories
• Neogen Corporation
• Ourofino Saúde Animal
• Bimeda
• Merck
• Biogénesis Bagó
• Ceva Sante Animal
• Dechra Pharmaceuticals
• Elanco Animal Health
• Boehringer Ingelheim International
• Phibro Animal Health
• PetIQ

Recent Development:

• In May 2025, Merck announced an $895 million expansion of a manufacturing facility based in De Soto, Kansas, which will include an investment in R&D labs associated with the facility. The expansion will provide a greater capacity for biologics/vaccines and novel therapeutics (such as parasiticides) with commercial production anticipated by 2030.
• In June 2025, Elanco released its 2024 Impact Report and announced a new framework around its “four key communities of impact” and stated eight core ambitions that embed its purpose into its operating activities. Elanco describes its innovation-based revenue, with contributions relevant to its parasiticide-related products (e.g. Credelio Quattro, Zenrelia), and continued access to parasite protection around the globe.

SCOPE OF THE REPORT:

• By Type

Prescription

Over the counter (OTC)

• By Drug Class

Pyrethroids

Chemical synthetic

Organophosphates

Benzimidazoles

Macrocyclic lactones

Other drug classes

• By Product

Endoparasiticides

Ectoparasiticides

Endectocides

• By Animal Type

Companion animals

Dogs

Cats

Horses

Other companion animals

Farm animals

Swine

Cattle

Poultry

Sheep and goats

Other farm animals

• By End Use

Animal farms

Veterinary hospitals and clinics

Home care settings

• By Region

North America (United States & Canada)

Europe (Germany, UK, France, Spain, Italy and Rest of Europe)

Asia-Pacific (China, Japan, India, South Korea, Australia and Rest of Asia-Pacific)

Latin America (Brazil, Mexico, Argentina and Rest of Latin America)

Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa and Rest of Middle East and Africa)

KEY REASONS TO PURCHASE THIS REPORT:

• It provides a technological development map over time to understand the industry’s growth rate and indicates how the animal parasiticides market is evolving.
• The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which animal parasiticides submarket will be the main driver of the overall market from 2026 to 2034.
• It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
• It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2034 and which country will lead the market in 2034.

Show more